Atria Wealth Solutions Inc. Has $1.75 Million Stock Position in CVS Health Corporation $CVS

Atria Wealth Solutions Inc. lowered its stake in CVS Health Corporation (NYSE:CVS) by 54.0% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 25,384 shares of the pharmacy operator’s stock after selling 29,858 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in CVS Health were worth $1,748,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Bell Investment Advisors Inc lifted its stake in shares of CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 248 shares during the period. Roxbury Financial LLC lifted its stake in shares of CVS Health by 78.3% in the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 202 shares during the period. ORG Partners LLC raised its stake in CVS Health by 418.9% during the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 377 shares during the period. Saudi Central Bank acquired a new stake in CVS Health during the 1st quarter worth $34,000. Finally, Livelsberger Financial Advisory acquired a new stake in CVS Health during the 2nd quarter worth $35,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. Mizuho raised their price objective on CVS Health from $76.00 to $88.00 and gave the stock an “outperform” rating in a research note on Thursday, October 9th. Bernstein Bank dropped their price objective on CVS Health from $78.00 to $72.00 and set a “market perform” rating on the stock in a research note on Wednesday, July 16th. Morgan Stanley raised their price objective on CVS Health from $82.00 to $89.00 and gave the stock an “overweight” rating in a research note on Tuesday. Baird R W raised CVS Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 14th. Finally, Barclays lifted their price target on CVS Health from $80.00 to $87.00 and gave the company an “overweight” rating in a research note on Thursday, September 4th. Two analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $81.05.

CVS Health Stock Performance

CVS opened at $80.75 on Thursday. The business’s 50-day moving average price is $73.30 and its two-hundred day moving average price is $67.92. CVS Health Corporation has a 1 year low of $43.56 and a 1 year high of $81.93. The company has a market capitalization of $102.42 billion, a price-to-earnings ratio of 22.56, a P/E/G ratio of 0.88 and a beta of 0.60. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.46 by $0.35. The company had revenue of $98.92 billion during the quarter, compared to analysts’ expectations of $94.87 billion. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.CVS Health’s revenue for the quarter was up 8.4% compared to the same quarter last year. During the same quarter last year, the company earned $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Equities analysts expect that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be issued a $0.665 dividend. The ex-dividend date is Thursday, October 23rd. This represents a $2.66 annualized dividend and a dividend yield of 3.3%. CVS Health’s dividend payout ratio (DPR) is presently 74.30%.

Insider Buying and Selling at CVS Health

In other news, Director Anne A. Finucane sold 7,500 shares of the firm’s stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the transaction, the director owned 22,156 shares in the company, valued at $1,573,519.12. This trade represents a 25.29% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.22% of the stock is owned by insiders.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.